"Jan. 4, 2013 -- A new study from Australia may offer a new way of identifying people at risk of glaucoma years before vision loss happens.
Glaucoma is a leading cause of blindness. But because vision damage often occurs gradually, mos"...
Ocular or Periocular Infections
EYLEA is contraindicated in patients with ocular or periocular infections.
Active Intraocular Inflammation
EYLEA is contraindicated in patients with active intraocular inflammation.
EYLEA is contraindicated in patients with known hypersensitivity to aflibercept or any of the excipients in EYLEA. Hypersensitivity reactions may manifest as severe intraocular inflammation.
Last reviewed on RxList: 2/7/2014
This monograph has been modified to include the generic and brand name in many instances.
Additional Eylea Information
Report Problems to the Food and Drug Administration
Get breaking medical news.